Dr Elbert Campbell Collins, MD | |
25647 Redwood Hwy, Cave Junction, OR 97523-9332 | |
(541) 592-4111 | |
(541) 592-3782 |
Full Name | Dr Elbert Campbell Collins |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology |
Location | 25647 Redwood Hwy, Cave Junction, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801891767 | NPI | - | NPPES |
180909 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | MD14732 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Elbert Campbell Collins, MD 25647 Redwood Hwy, Cave Junction, OR 97523-9332 Ph: (541) 592-4111 | Dr Elbert Campbell Collins, MD 25647 Redwood Hwy, Cave Junction, OR 97523-9332 Ph: (541) 592-4111 |
News Archive
Pfizer Inc. announced today it is planning regulatory submissions of bosutinib in patients with chronic myeloid leukemia (CML) based on data from a clinical program evaluating the compound in newly diagnosed and previously treated patients. These regulatory submissions are planned for 2011.
Hospital TeamCare is proud to launch its newest physician services – Hospital Medicine, and Pediatrics. These new physician services will be offered throughout all existing US market areas.
Researchers conducted a prospective observational study in elderly patients and adult patients receiving antiplatelet therapy who presented with mild head injury at two trauma hospitals in Vienna: the Trauma Hospital Meidling and the Donauspital.
A potentially life-threatening challenge characterized by pauses in breathing that can last for more than 20 seconds, apnea of prematurity (AOP) affects more than 50 percent of premature infants and is almost universal in the smallest of preemies. Caused in part by an underdeveloped central nervous system that can't adequately regulate breathing outside of the womb, especially during sleep, AOP is not yet fully understood by scientists and remains a grave concern among neonatologists and parents alike.
Chemotherapy is one of the most common treatments for cancer patients. However, many patients suffer from serious side-effects and a large proportion does not respond to the treatment. Researchers from the Biotech Research and Innovation Centre (BRIC) and Center for Healthy Aging, University of Copenhagen, now show that the gene FBH1 helps turn up the effect of chemotherapy.
› Verified 1 days ago